C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 417/04 (2006.01) A61K 31/427 (2006.01) A61K 31/4439 (2006.01) A61K 31/497 (2006.01) A61K 31/506 (2006.01) A61P 3/04 (2006.01) C07D 417/14 (2006.01)
Patent
CA 2511905
The present invention relates to compounds of formula (1) wherein R1, R2, R3, R4, R5, R6 and R7 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CBI receptors.
L'invention concerne des composés de formule générale (I), dans laquelle R?1¿, R?2¿, R?3¿, R?4¿, R?5¿, R?6¿ et R?7¿ ont la signification indiquée dans la description et les revendications, et des sels acceptables sur le plan pharmaceutique de ceux-ci. Ces composés sont utiles pour le traitement et/ou la prophylaxie de maladies associées à la modulation des récepteurs CB1.
Guba Wolfgang
Haap Wolfgang
Marty Hans Peter
Narquizian Robert
F. Hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Novel cb 1 receptor inverse agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel cb 1 receptor inverse agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel cb 1 receptor inverse agonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1444758